Chang Gung University
Taoyuan, 333, Taiwan
NCT Number: NCT02122653
Muscle strength and endurance are important indexes of fitness. The muscle strength is the most important single predict factor of functional ability in aged frail individuals. Frailty related muscle weakness and fatigue are adapted from the pre-frail stage. Finding the contributions of the central and the peripheral factors to the deficits of muscle fitness and developing an effective muscle fitness training program for pre-frail individuals are very important.
The muscle weakness and fatigue can be categorized into peripheral or central causes. The central fatigue and voluntary activation failure originate from the decrease in motivation or the reduction of the conduction within corticospinal tracts. Long term activation failure and central fatigue will cause disuse of muscle and result in peripheral weakness and peripheral fatigue. Studies found the selective type II fiber atrophy in aged people and this finding was different from the type I atrophy in conventional immobilization models. It is possible that the activation failure leads to the recruitment failure of high threshold type II fibers at the pre-frail stage. Quantifying the weighting of central versus peripheral factors contributing to the exercise limitation in pre-frail people is important.
Most of the conventional strength and endurance training programs are based on the researches of young groups. These programs are not able to prevent people become frail. It is possibly that, due to the limitation of central fatigue, the pre-frail individuals stop exercise before the effective intensity being achieved. Almost no training program has been design for enhancing the voluntary activation level and relief the central fatigue. Seeking an appropriate training program to enhance central activation at the pre-frail stage is very important for preventing people become frail.
Previous studies have shown that increasing afferent input by peripheral electrical stimulation (ES) at sensory threshold enhanced the plasticity of contralateral primary sensory cortex, the excitability of corticospinal tracts, and the functional performance in young adults. ES, which is easy to quantify the dose of afferent input, is a feasible method to be used in training. Combining afferent input with strength training might be able to overcome the central activation failure and help recruit high threshold motor unit in pre-frail individuals.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Taoyuan, 333, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Health subjects:
Exclusion criteria
Musculoskeletal injuries for knee. Osteoporosis. Diabetes.
Participants will perform 4 weeks of Weight training for lower extremities.
Participants will perform 4 weeks of electrical stimulation for Quadriceps muscle belly.
Time frame: Baseline, 4 weeks,8 weeks.
Measure of changes in muscle twitch force by interpolation twitch technique.
Time frame: Baseline, 4 weeks,8 weeks.
Measure of changes in muscle voluntary activity level by interpolation twitch technique.
Time frame: Baseline, 4 weeks,8 weeks.
Measure of changes in the central activation and the excitability of motor cortex by Transcranial magnetic stimulation.
Time frame: Baseline, 4 weeks,8 weeks.
Measure of changes in muscle strength test for lower extremities by clinical test.
Chang Gung University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02804594
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
San Francisco, California, United States
View Trial DetailsNCT07149272
Behavior, Fatigue
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
View Trial DetailsNCT05256888
Behavior, Diet Therapy
Baltimore, Maryland, United States
View Trial DetailsNCT07047105
Cognition, Fatigue
Newcastle upon Tyne, United Kingdom
View Trial Details